© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Moving to Turkey. Things You Should to Pay Attention To
News
09/05/2023Moving to Turkey. Things You Should to Pay Attention To

Moving to another country can be quite a complicated and challenging process, so it is necessary to prepare well and take into account many factors. 

Read Full PostRead - Eye Icon
Smaller Companies Choose IPOs to Fund Growth
Finance
03/03/2015Smaller Companies Choose IPOs to Fund Growth

The volume and value of Initial Public Offerings (IPOs) on London's junior market increased last year as SMEs sought funding for growth, according to data from global information services company Experian.

Read Full PostRead - Eye Icon
What is a Financial Adviser?
Finance
05/06/2023What is a Financial Adviser?

If you’re looking for the most effective way to build your wealth and achieve a successful financial outcome in your situation, there’s one key thing you will want to consider:

Read Full PostRead - Eye Icon
The Rise of Sustainable Business Practices: Strategies for Balancing Profit and Purpose
News
06/06/2023The Rise of Sustainable Business Practices: Strategies for Balancing Profit and Purpose

As business owners, executives, and professionals, we must ensure that our businesses succeed while striving to be socially conscious. As a result, sustainability has become a priority for many organizations as they seek to ensure long-term success and priorit

Read Full PostRead - Eye Icon
A Brazilian Influence
Leadership
07/07/2022A Brazilian Influence

Fernanda Marques, Director of Fernanda Marques Arquitetos Associados, is a graduate of the Faculty of Architecture and Urbanism of São Paulo, FAU USP. Her work follows the same conceptual line that characterised her years of training - the integrated exercise

Read Full PostRead - Eye Icon
5 Top-Rated Advisory Services for Mergers and Acquisitions
News
25/03/20255 Top-Rated Advisory Services for Mergers and Acquisitions

Mergers and acquisitions can drive remarkable growth, but they’re sometimes challenging to understand. Getting expert help from a qualified, knowledgeable advisor is crucial if you hope to maximise your returns and avoid complicated tax and legal issues.

Read Full PostRead - Eye Icon
Legal Project Management – The Forgotten Aspect of M&A Transactions
Strategy
31/07/2016Legal Project Management – The Forgotten Aspect of M&A Transactions

Arnecke Sibeth is highly renowned independent law firm based in Germany. We got in touch with Michael Siebold, partner at the company, to find out more about his firm and discover his thoughts on the ever-growing importance of legal project management.

Read Full PostRead - Eye Icon
CEO of the Year, California
Leadership
02/02/2016CEO of the Year, California

Ghost Systems, Inc. (Ghost) was formed in January 2014.

Read Full PostRead - Eye Icon
Measuring Success in Change Management: Metrics, KPIs, and Evaluation Methods
News
23/05/2024Measuring Success in Change Management: Metrics, KPIs, and Evaluation Methods

Change practitioners are expected to measure the contributions of all their change management activities in order to achieve the desired success on their projects. Change is something that every organization needs to go through to progress.  By adopting t



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow